Vorapaxar expands antiplatelet options. Which patients may benefit from thrombin receptor antagonism? Duerschmied D, Bode C. Hamostaseologie. 2012;32(3):221-7. doi: 10.5482/HAMO-12-05-0006. Epub 2012 Jul 10. PMID: 22777302

Activity: Other activity typesOther

Period2012